rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael Salsbury

Director

Company insider

Files Form 4 as: Director, MetaVia.

In numbers

Trades disclosed
8
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
13 Jan 2020
Last trade
8 Jun 2026
Last filed
8 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MTVA MetaViaDirector · Biotechnology · last 8 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 8 Jun 2026MTVA MetaViaBiotechnologySEC FORM 4 Code A—17,186 at $0.00filing
8 Jun 2026filed 8 Jun 2026MTVA MetaViaBiotechnologySEC FORM 4 Code A—17,186 at $0.00filing
30 Jun 2025filed 1 Jul 2025MTVA MetaViaBiotechnologySEC FORM 4 Code A—28,147 at $0.00filing
7 Jun 2024filed 7 Jun 2024MTVA MetaViaBiotechnologySEC FORM 4 Code A—5,051 at $0.00filing
27 Jul 2023filed 28 Jul 2023MTVA MetaViaBiotechnologySEC FORM 4 Code A—87,500 at $0.00filing
27 Jul 2023filed 28 Jul 2023MTVA MetaViaBiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
9 Jun 2022filed 10 Jun 2022MTVA MetaViaoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
13 Jan 2020filed 15 Jan 2020MTVA MetaViaoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Sarah Kaplan BrowneChief Medical Officer · Chief Medical Officer at MetaVia, filing Form 4 there in the last year
Andrew I. KovenDirector · Director at MetaVia, filing Form 4 there in the last year
Mark A. GlickmanDirector · Director at MetaVia, filing Form 4 there in the last year
Jason L. GrovesDirector · Director at MetaVia, filing Form 4 there in the last year
James Patrick TursiDirector · Director at MetaVia, filing Form 4 there in the last year